• MedStar Cardiovascular Research Network Selected by Society for Cardiovascular Angiography and Interventions to Manage New Quality Improvement and Research Platform

    March 05, 2019

    WASHINGTON– David Cox, MD, MSCAI, President of the Society for Cardiovascular Angiography and Interventions (SCAI), and Ron Waksman, MD, FSCAI, Director of MedStar Cardiovascular Research Network (MCRN) announced today at the Cardiovascular Research Technologies (CRT) 2019 meeting in Washington, DC a joint venture for MedStar to manage the data warehousing and analysis services for clinical, procedural, and outcomes data for SCAI’s quality improvement and research initiatives.

     “We chose MCRN to provide data collection and data analysis for SCAI’s quality improvement and research initiatives as they have a proven track record in cardiovascular research and large-scale clinical trials,” says David Cox, MD, MSCAI. “It’s a natural fit for the work we do at SCAI.”

    “I’m excited to announce this venture for MCRN to partner with SCAI for this transformative work.  Our interventional community is looking for leadership within areas such as mechanical circulatory support, Patent Foramen Ovale closure, and pulmonary embolism treatment response.  Such objective data collection and research questions supported by SCAI will benefit the interventional cardiology community and our patients,” Ron Waksman, MD said.  

    ###

    ABOUT SCAI
    The Society for Cardiovascular Angiography and Interventions (SCAI) is the premier medical society leading the global interventional cardiovascular community through education, advocacy, research, and quality patient care. SCAI represents more than 5,000 members across 75 countries. For more information about SCAI, visit www.scai.org and www.secondscount.org. Follow @SCAI on Twitter for the latest heart health news.

    ABOUT MHVI/MCRN
    MedStar Heart & Vascular Institute (MHVI) is the leading cardiovascular program in the Mid-Atlantic Region providing comprehensive care and treatment for complex cardiovascular disorders throughout the Mid-Atlantic region. MedStar Cardiovascular Research Network (MCRN) prides itself on the robust activity of its clinical research coordination that facilitates enrollment for more than 100 trials annually across all cardiovascular disciplines. MCRN also collaborates with the National Institutes of Health, Food and Drug Administration, the Centers for Medicare and Medicaid Services, the Cleveland Clinic, and other leading institutions in the USA and globally.